Nasonex Nasal Spray

Company
Schering-Plough

Approval Status
Approved January 1999

Treatment for
Immunology/Allergy

Nasonex has been approved for the prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and the treatment of the nasal symptoms of perennial allergic rhinitis, in adults and children 12 years of age and older.

Nasonex Nasal Spray Drug Information

The Nasonex Nasal Spray drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top